Catalyst Wire Dossier Catalyst Wire Dossier

STEGLATRO

ertugliflozin · Merck Sharp & Dohme LLC
Drug timelines are a Plus or Pro feature.

18 regulatory and trial events tracked for STEGLATRO, covering 2017-12-19 to 2026-02-13. Get the full timeline:

Most recent: Clinical Trial Update: Adult Congenital Heart Disease International EValuation of the Effectiveness of SGLT2i Registry

See pricing